Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB3 | P13945 | 16/20 | 0.98 |
| ▸ | ADRB1 | P08588 | 14/20 | 0.98 |
| ▸ | NPC1 | O15118 | 3/20 | 0.59 |
| ▸ | RAB9A | P51151 | 3/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | MITF | O75030 | 2/20 | 0.51 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.47 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7531125 | 0.92 | ADRB3 (0.86) | ADRB3ADRB1NPC1RAB9AMEN1 | |
| SCHEMBL6539152 | 0.91 | ADRB3 (0.85) | ADRB3ADRB1NPC1RAB9AMEN1 | |
| SCHEMBL6538626 | 0.91 | ADRB3 (1.00) | ADRB3ADRB1ADRB2 | |
| Hydrochloric Acid SCHEMBL6538594 | 0.90 | ADRB3 (0.98) | ADRB3ADRB1ADRB2 | |
| Trifluoroacetic Acid SCHEMBL6538586 | 0.89 | ADRB3 (0.81) | ADRB3ADRB1NPC1RAB9AMEN1 | |
| SCHEMBL6538836 | 0.89 | ADRB3 (0.81) | ADRB3ADRB1NPC1RAB9AMEN1 | |
| SCHEMBL6538752 | 0.88 | ADRB3 (0.83) | ADRB3ADRB1NPC1RAB9AMEN1 | |
| SCHEMBL6539731 | 0.88 | ADRB3 (1.00) | ADRB3ADRB1NPC1RAB9AMEN1 | |
| Trifluoroacetic Acid SCHEMBL6539079 | 0.87 | ADRB3 (0.77) | ADRB3ADRB1NPC1RAB9AMEN1 | |
| SCHEMBL7531078 | 0.86 | ADRB3 (0.80) | ADRB3ADRB1NPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6826033-B2 | BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| WO-2002024635-A2 | AMINOALCOHOL DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-28 | — | — | WO | disclosed |